3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 3
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Motor Activity
2
Melanoma
2
Breast Neoplasms
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Testicular Neoplasms
1
Squamous Intraepithelial Lesions
1
Sezary Syndrome
1
Recurrence
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Prostate Adenocarcinoma
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Pain
1
Oropharyngeal Neoplasms
1
Neuroblastoma
1
Neoplasms
1
Myeloproliferative Disorders
1
Mycosis Fungoides
1
Multiple Myeloma
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphedema of Face
1
Interventions
Zidovudine
3
Tobacco Use Cessation Devices
2
Surveys and Questionnaires
2
Methotrexate
2
Leucovorin
2
Electrocoagulation
2
Dexamethasone
2
Watchful Waiting
1
Vincristine
1
Trichloroacetic Acid
1
Transurethral Resection of Prostate
1
Tomography, X-Ray Computed
1
Therapeutics
1
Self Care
1
Rapid Diagnostic Tests
1
Occult Blood
1
Observation
1
Mammography
1
Inosine Pranobex
1
Fluorouracil
1
Enzyme-Linked Immunosorbent Assay
1
Doxorubicin
1
Cytarabine
1
Cyclophosphamide
1
Bleomycin
1
Biopsy
1
Benzethonium
1
Amyloid
1
Allopurinol
1
Acetic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Acquired Immunodeficiency Syndrome
×
Observation
×
Clear all
NCT02503111
2022-06-13
HPV-SAVE
University Health Network, Toronto
Phase NA
Terminated
71 enrolled